SOURCE: THE GATEWAY PUNDIT
By Jim Hoft
Published October 13, 2021 at 8:20am
Lifesite News reported:
On July 13, the boy’s mother filed a report with the Vaccine Adverse Event Reporting System (VAERS) — run by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) — indicating her son died 27 days after receiving his second dose of Pfizer’s experimental COVID-19 vaccine in April.
“My son died, while taking his math class on Zoom. We are waiting for the autopsy because the doctors did not find anything,” the mother wrote. “He was a healthy boy, he had a good academic index, he wanted to be a civil engineer. He was the best thing in my life.”
In the “Diagnostic Lab Data” section of the VAERS entry, the mother wrote, “He had no previous symptoms. I was with him one hour before and my assistant saw him 20 minutes prior and he did not show any irregularities.”
Per the report, the child’s second dose was administered on April 3, and the boy died on April 27.
The entry also indicates that the child had not been diagnosed with any allergies, pre-existing conditions, illnesses, disabilities, or birth defects, and had not been taking any medications prior to his death. He apparently stayed in the hospital for eight days, and it’s unclear how he participated in the Zoom class, or if he was released prior.
Here is the information from National Vaccine Information Center with VAERS ID 1466009 from the 10/1/2021 release of VAERS data:
One thought on “Healthy 16-Year-Old Boy Dies During Online Class After Receiving Second COVID Shot from Pfizer”
the United States of Russia
Comments are closed.